The Human body is made up of over 100 trillion of microbes which have outnumbered human cells ten to one. The human body is an ecosystem i.e. home to trillions of microbes like bacteria, fungi, virus, etc. and the community of the microbes that resides in it is known as the human microbiome. The human microbiome is an aggregation of the microbes that reside on or within the body fluids or tissues. These communities play an important role in human physiology, immune system development, digestion, and detoxification reactions.
This report provides an in-depth diverse perspective and the importance of human microbiome in health and disease-related conditions. Alterations in human microbiome occur by exposure to various extrinsic factors like diet, xenobiotics, drugs as well as pathogens which contribute to the pathogenesis of various metabolic, neurological, immunological, and cancer-promoting diseases . It will also disclose the key aspects of the human microbiome as well as the current biotechnological tools and techniques for studying the human microbiome.
Various human microbial studies are known to identify and categorize the bacterial taxa and functions that are shared by a majority of individuals. This report will cover the factors which can affect the human microbiome as well as various studies which are well known and can be used as a tool for identifying the potential of the functional microbiome. It will also emphasize on the various microbiome-based markers which can be useful in determining the disease or the risk of disease and various approaches like Fecal Microbiota Transplant (FMT), Genetically engineered probiotics, etc. which have a profound effect in improving the microbiome condition.
According to the reported data, the global human microbiome market is nearly expected to grow by $521.23 million in 2022. This report covers its market trends analysis and its growth in the commercial market. It will also include the major key players like Agilent technologies, Abbott, Biocartis, etc. which are actively working in this field and will also be discussed its future market scenario.
This report will also focus on global market competitive analysis as well as the Major competitors/players in this market which are actively working on the human microbiome. It will also discuss the agreements, partnerships, collaborations/ Joint Ventures, acquisitions/mergers, new products launch, other key strategies in this field.
This report provides an in-depth diverse perspective and the importance of human microbiome in health and disease-related conditions. Alterations in human microbiome occur by exposure to various extrinsic factors like diet, xenobiotics, drugs as well as pathogens which contribute to the pathogenesis of various metabolic, neurological, immunological, and cancer-promoting diseases . It will also disclose the key aspects of the human microbiome as well as the current biotechnological tools and techniques for studying the human microbiome.
Various human microbial studies are known to identify and categorize the bacterial taxa and functions that are shared by a majority of individuals. This report will cover the factors which can affect the human microbiome as well as various studies which are well known and can be used as a tool for identifying the potential of the functional microbiome. It will also emphasize on the various microbiome-based markers which can be useful in determining the disease or the risk of disease and various approaches like Fecal Microbiota Transplant (FMT), Genetically engineered probiotics, etc. which have a profound effect in improving the microbiome condition.
According to the reported data, the global human microbiome market is nearly expected to grow by $521.23 million in 2022. This report covers its market trends analysis and its growth in the commercial market. It will also include the major key players like Agilent technologies, Abbott, Biocartis, etc. which are actively working in this field and will also be discussed its future market scenario.
This report will also focus on global market competitive analysis as well as the Major competitors/players in this market which are actively working on the human microbiome. It will also discuss the agreements, partnerships, collaborations/ Joint Ventures, acquisitions/mergers, new products launch, other key strategies in this field.
Table of Contents
1 Table of Contents
4 Human Microbiome: Overview
9 Technical Analysis
12 Market Analysis
13 Market Trend Analysis
14 Key Microbiome Players (Company Profiling)
15 Key Microbiome Developments
List of Tables
List of Figures
Companies Mentioned
- 4D Pharma plc
- AOBiome, LLC
- Abbott Diagnostics
- Agilent Technologies Inc.
- Anaeropharma Science
- Aperiomics, Inc.
- Atlas Biomed
- AvidBiotics
- Beckman Coulter / Danaher
- Becton, Dickinson and Company (BD)
- Biocartis Group
- C3J Therapeutics (formerly C3 Jian)
- Crestovo (Finch Therapeutics Group)
- Danaher Corporation
- Eppendorf AG
- Evelo Biosciences
- Evolve Biosystems
- Finch Therapeutics Group
- One Codex
- OpenBiome
- Optibiotix
- OraSure Technologies, Inc.
- Osel, Inc.
- PerkinElmer, Inc. (Pe)
- Pfizer, Inc.
- Phase Genomics
- Proderm IQ
- Prodigest
- Promega Corporation
- PureFlora Inc.
- QIAGEN
- Quay Pharma
- Whole Biome
- Xycrobe Therapeutics, Inc.
- Zymo Research
Methodology
LOADING...